Header Logo

Connection

LUCAS WONG to Survival Rate

Back to Details
This is a "connection" page, showing publications LUCAS WONG has written about Survival Rate.
LUCAS WONG
Connection Strength
0.014
Survival Rate
  1. Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336). Invest New Drugs. 2009 Oct; 27(5):469-75.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.